Bruker Corporation (BRKR)
NASDAQ
Closed
Aug 24, 2026
Day's Range
56.9152 wk Range
28.53Overview - BRKR - Bruker Corporation
Key Statistics
Valuation
Enterprise Value
10.79B
P/E (Trailing)
‪74.88‬
P/E (Forward)
‪24.75‬
PEG Ratio
‪-0.08‬
Price / Sales (TTM)
‪2.59‬
Price / Book
‪3.81‬
EV / EBITDA
‪19.95‬
Profitability
Gross Margin
‪49.61%‬
Profit Margin
‪-2.03%‬
Operating Margin
‪9.87%‬
Return on Assets
‪3.13%‬
Return on Equity
‪-2.99%‬
Ownership
Shares Outstanding
152.35M
Float
103.68M
Short % of Shares Outstanding
‪16.04%‬
Held by Insiders
‪26.96%‬
Held by Institutions
‪95.73%‬
Price stats
Beta
‪1.27‬
50-Day Avg
‪58.47‬
200-Day Avg
‪47.18‬
Dividends
Payout Ratio
‪38.45%‬
Frequency
Quarterly
Analyst Consensus
13 analysts
Average price target
‪$ 58.75‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - BRKR - Bruker Corporation
Peers - BRKR - Bruker Corporation
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
Profile Summary - BRKR - Bruker Corporation
About
Bruker Corporation is a leading developer and manufacturer of high-performance scientific instruments and analytical solutions that enable molecular and materials research across academic, governmental, and industrial laboratories worldwide. The company designs and distributes nuclear magnetic resonance spectrometers,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
